In those evaluations, sensitivity improved greatly at lower CD4 counts, e.g. for confirmed TB from around 20% if CD4≥100x106/l to >50% if CD4 <100x106/l; our improvement from 10% to 17% is in accord although still not useful for screening. The gene discussed is CD4; the disease is tuberculosis.